NCT02259933View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of KUC 7483 CL Tablets in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

May 31, 2004

Conditions
Healthy
Interventions
DRUG

KUC 7483 CL

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02259933 - Safety, Tolerability and Pharmacokinetics of KUC 7483 CL Tablets in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter